June 1, 2020 / 11:07 AM / a month ago

BRIEF-Bristol Myers Squibb Reports Commercial Launch Of Zeposia For Multiple Sclerosis

June 1 (Reuters) - Bristol-Myers Squibb Co:

* BRISTOL MYERS SQUIBB ANNOUNCES COMMERCIAL LAUNCH AND AVAILABILITY OF ZEPOSIA® (OZANIMOD), A NEW ORAL TREATMENT FOR RELAPSING FORMS OF MULTIPLE SCLEROSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below